Interpace Diagnostics Group stock (IDXG) is down: expect recovery?

10:23 am ET, 06 Aug 2018

Interpace Diagnostics Group, Inc. (IDXG) shares are trading at 1.01, up 2%. What's driving IDXG stock price?  What news should IDXG investors be aware? 

Interpace Diagnostics Group stock popped recently because the company received a letter from NASDAQ about regaining compliance with the requirement to maintain a minimum closing bid price of $1.00 per share.  This closing bid minimum has been maintained between July 16 and July 27.  

There are some positive commercial developments for the company.  The mega-insurer Cigna stated it will cover ThyraMIR, a microRNA gene expression classifier for thyroid nodules, that Interpace Diagnostics developed.  

The health insurer has covered another IDXG's drug ThyGenX since 2017.  80% of ThyGenX orders are coupled with an order for ThyraMIR, and the two tests are billed independently.

What is the sentiment towards the IDXG stock?  Our technical analysis shows that: 

  • The stock short-term sentiment (next 30 days) is positive;
  • The mid-term sentiment (3-6 months) is positive;
  • The long-term sentiment (9-12 months) is positive. 


Over the last month, Interpace Diagnostics Group, Inc. (IDXG) returned +14.44%.

Interpace Diagnostics Group, Inc. (IDXG) short share of float is 11.29%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock.

Interpace Diagnostics Group, Inc. (IDXG) average analyst price target ($3.50) is 239.81% above its current price ($1.03).

For the latest price and information on Interpace Diagnostics Group, Inc., please visit Finstead and search for "IDXG price" or "IDXG news".

Interpace Diagnostics Group, Inc. (IDXG) Stock Guide

Updated at: 1:03 am ET, 18 Sep 2020

Before we start: if you're looking for IDXG stock price, you can quickly find it out by visiting Finny and typing "IDXG quote". If you're looking for a quick scoop on IDXG stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "IDXG". You'll get all this info in one place. Or you can just type "IDXG news" to get the latest stock news.

Looking to buy or sell Interpace Diagnostics Group, Inc. (IDXG)? Interested in getting the full scoop on IDXG, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this IDXG stock guide, we'll address key questions about IDXG, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are IDXG earnings?
2. What is IDXG stock forecast (i.e., prediction)?
3. IDXG buy or sell? What is IDXG Finny Score?
4. What are the reasons to buy IDXG? Why should I buy IDXG stock?
5. What are the reasons to sell IDXG? Why should I sell IDXG stock?
6. What are IDXG key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are IDXG earnings?

IDXG trailing 12-month earnings per share (EPS) is -$9.32.

Analyst Predictions

2. What is IDXG stock forecast (i.e., prediction)?

Based on IDXG analyst price targets, IDXG stock forecast is $13.45 (for a year from now). That means the average analyst price target for IDXG stock is $13.45. The prediction is based on 1 analyst estimates.

The low price target for IDXG is $9.25, while the high price target is $20.00.

IDXG analyst rating is Buy.

Analysis

3. IDXG buy or sell? What is IDXG Finny Score?

#{finnyScore:75}Our quantitative analysis shows 6 reasons to buy and 2 reasons to sell IDXG, resulting in Finny Score of 75.

4. What are the reasons to buy IDXG? Why should I buy IDXG stock?

Here are the reasons to buy IDXG stock:

  • The company is engaged in providing personalized medicines, a growing medical field. It also offers specialized services along the therapeutic value chain to therapeutic applications.
  • Cancer molecular diagnostics for screening and treatment planning using genetics, a field that IDXG engages in, has generated considerable industry and investor interest. Some companies such as Foundation Medicines (FMI) and Genomic Health (GHDX) were acquired for ~10x revenue.
  • IDXG quarterly revenue growth was 53.10%, higher than the industry and sector average revenue growth (1.20% and 0.83%, respectively). See IDXG revenue growth chart.
  • IDXG Price/Book ratio is 1.92, which is low compared to its industry peers’ P/B ratios. See IDXG forward Price/Book ratio chart.
  • IDXG Price/Sales ratio is 0.48, which is low compared to its industry peers’ P/S ratios. See IDXG forward Price/Sales ratio chart.
  • IDXG average analyst rating is Buy. See IDXG analyst rating chart.
  • IDXG average analyst price target ($13.45) is above its current price ($3.32). See IDXG price target chart.
  • IDXG cash to debt ratio is 3.28, higher than the average industry (0.21) and sector (0.16) cash to debt ratio. See IDXG cash to debt chart.

5. What are the reasons to sell IDXG? Why should I sell IDXG stock?

Let's look at the reasons to sell IDXG stock (i.e., the bear case):

  • Investors' sentiment has been negative partly because of the reverse stock split, continued capital raises, dilution and cash constraints.
  • IDXG profitability is declining. The YoY profit margin change was -13.17 percentage points. See IDXG profitability chart.
  • IDXG short share of float is 5.83%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See IDXG short share of float chart.

Key Stats

6. What are IDXG key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for IDXG:

Metrics IDXG
Price $3.06
Average Price Target / Upside $13.45 / 339.54%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Diagnostics & Research
Sector Healthcare
Number of Employees 75
Market Cap $13.08M
Forward P/E Ratio -1.52
Price/Book Ratio 0.48
Revenue (TTM) $27.27M
YoY Quarterly Revenue Growth 53.10%
Profit Margin -119.56%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us